Fardous F. El‐Senduny

ORCID: 0000-0002-4572-2061
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Synthesis and biological activity
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Bioactive Compounds and Antitumor Agents
  • Synthesis and Biological Evaluation
  • Cancer, Lipids, and Metabolism
  • Cancer therapeutics and mechanisms
  • Cancer-related Molecular Pathways
  • Natural product bioactivities and synthesis
  • Cancer Treatment and Pharmacology
  • Organic Chemistry Cycloaddition Reactions
  • Cancer Mechanisms and Therapy
  • Click Chemistry and Applications
  • Nanoparticles: synthesis and applications
  • Genomics, phytochemicals, and oxidative stress
  • Phytochemical compounds biological activities
  • Organoselenium and organotellurium chemistry
  • Curcumin's Biomedical Applications
  • Marine Biology and Environmental Chemistry
  • Ferrocene Chemistry and Applications
  • Nanoparticle-Based Drug Delivery
  • Vitamin D Research Studies
  • Synthesis of Tetrazole Derivatives
  • DNA and Nucleic Acid Chemistry
  • Cholinesterase and Neurodegenerative Diseases

Mansoura University
2015-2025

Sylvester Comprehensive Cancer Center
2022-2025

Suez Canal University
2023

South Dakota State University
2015

King Abdulaziz University
2014

Spirooxindole is a promising chemo therapeutic agent. Possible targets include cancers of the liver, prostate, lung, stomach, colon, and breast. Here, we demonstrate one-pot three-component reaction via [3 + 2] cycloaddition/ring contraction sequence dipolarophile (activated alkene) with in situ-generated azomethine ylide (1,3-dipoles) without use any catalyst. The provides efficient access to synthetically useful biologically important spirooxindoles high yield (69-94%)...

10.1039/c8ra02358a article EN cc-by RSC Advances 2018-01-01

Ovarian cancer is the most deadly gynecological cancer. The first line in treatment platinum-based drugs. However, patients suffer from tumor recurrence, characterized by resistance to cisplatin. A plausible approach address co-administer chemotherapeutic agents along with natural products offer a synergistic effect and optimize dosage regimen. Cucurbitacin B product displays antitumor activity against wide array of cell lines. aim this work determine ovarian (A2780) possible sensitization...

10.1007/s13277-015-3773-8 article EN Tumor Biology 2015-08-04

Hepatocellular carcinoma is a highly aggressive and difficult-to-treat type of cancer. Incorporating urea functionality into the backbone organoselenium compounds expected to develop promising chemotherapeutic leads against liver Methods: Urea-functionalized were synthesized in good yields, their cytotoxicity was evaluated HepG2 cells. Results: 1,1'-(Diselanediylbis(4,1-phenylene))bis(3-phenylurea) (14) exhibited efficient anti-HepG2 activity sub-micromolar concentrations, with no toxicity...

10.4155/fmc-2021-0114 article EN Future Medicinal Chemistry 2021-08-24

Objectives: This in vivo study introduces a newly developed spirooxindole derivative that is deemed safe and effective as potential targeted therapy for various cancers. Methods: Extensive investigations, including histopathology, immunohistochemistry, molecular biology, validated its further preclinical clinical exploration, necessitating comprehensive examinations of bioavailability, pharmacodynamics, pharmacokinetics. Additionally, this involves the development commercially viable...

10.3390/pharmaceutics17010093 article EN cc-by Pharmaceutics 2025-01-12

Thiourea derivatives bearing sulfonamide moiety are well known for their anticancer activity.The activity of the target compounds was studied, via inhibition COX-2 enzyme.A series novel thioureas 5a-n, 8, quinazoline 6, benzo[g]quinazoline 7 and benzo[1,3] dioxole 10, a synthesized from starting compound N-(2,6-dimethoxypyrimidin-4-yl)-4- isothiocyanatobenzenesulfonamide 2. The were screened against HepG2, MCF-7, Caco-2, HCT-116, PC-3 cancer cell lines VERO-B normal line.Out all tested...

10.2174/1871520617666170327153735 article EN Anti-Cancer Agents in Medicinal Chemistry 2017-03-30

A one-pot, single-step, and an atom-economical process towards the synthesis of highly functionalized spirooxindoles analogues was efficiently conducted to produce a satisfactory chemical yields (70–93%) with excellent relative diastereo-, regio-selectivity. An in vitro antiproliferative assay carried out on different cancer cell lines evaluate biological activity synthesized tetrahydro-1’H-spiro[indoline-3,5’-pyrrolo[1,2-c]thiazol]-2-one 5a–n. The prepared hybrids were then tested for their...

10.3390/app10062170 article EN cc-by Applied Sciences 2020-03-23

The low amount of metabolites isolated from natural products is one the challenges preventing their biological evaluation. modulation biosynthetic pathways by stimulating stress-induced responses in plants was proven to be a valuable tool for diversification already known products. Recently, we reported dramatic effect methyl jasmonate (MeJA) on Vinca minor alkaloids distribution. In this study, three compounds identified as 9-methoxyvincamine, minovincinine, and minovincine are successfully...

10.1055/a-2058-3863 article EN Planta Medica 2023-03-20

In this work, the natural piperine moiety was utilised to develop two sets of piperine-based amides (5a-i) and ureas (8a-y) as potential anticancer agents. The action assessed against triple negative breast cancer (TNBC) MDA-MB-231, ovarian A2780CP hepatocellular HepG2 cell lines. particular, 8q stood out most potent anti-proliferative analogue TNBC MDA-MB-231 cells with IC50 equals 18.7 µM, which is better than that (IC50 = 47.8 µM) 5-FU 38.5 µM). Furthermore, investigated for its possible...

10.1080/14756366.2021.1988944 article EN cc-by Journal of Enzyme Inhibition and Medicinal Chemistry 2021-12-11

Abstract A novel series of coumarin‐thiadiazole heterocycle derivatives was synthesized by the nucleophilic substitution reaction. The compounds were structurally verified IR, 1 H NMR, 13 C mass spectra, and elemental analyses. antitumor activity evaluated through DNA binding assays 60‐cell line panel according to US NCI‐DTP protocol or a selection human tumor cell lines: breast cancer (MCF‐7), liver (HepG‐2), colorectal (HCT‐116). Most had better DNA/ethidium bromide fluorescence quenching...

10.1002/ardp.201700199 article EN Archiv der Pharmazie 2017-11-17

Acetylcholinesterase inhibitors (AChE-Is) increase both level and duration of action acetylcholine (ACh); thus, alleviate symptoms Alzheimer's disease (AD). Glycyrrhizin, is the main active compound in liquorice root. Its aglycone, glycyrrhetinic acid, has shown several beneficial pharmacological activities. This study reports synthesis screening a series acid analogs as AChE-Is. Fourteen derivatives were prepared, which five are recorded new viz., 3-phenyl-carbamoyl-18β-glycyrrhetinic (J9),...

10.1080/14786419.2018.1462177 article EN Natural Product Research 2018-04-16

We herein report a new small library of Schiff-base compounds that encompasses s-triazine and (2 or 4)-hydroxylbenzylidene derivatives. These were synthesized through hydrazone linkage connecting both the hydroxybenzylidene The synthetic strategy adopted allowed synthesis target with excellent yields purities as observed from their NMR ( 1 H 13 C) elemental analysis. Furthermore, 4f , 5b 5f further confirmed by X-ray single crystal diffraction technique. preliminary antiproliferative...

10.1155/2019/9403908 article EN cc-by Journal of Chemistry 2019-04-30

Over the past few decades, development of broad-spectrum anticancer agents with anti-angiogenic activity has witnessed considerable progress. In this study, a new series pyrazolo[3,4-d]pyrimidines based on phenylfuroxan scaffold were designed, synthesized, and evaluated, in terms their activities. NCI-60 cell one-dose screening revealed that compounds

10.3390/ph15020246 article EN cc-by Pharmaceuticals 2022-02-18

Myxofibrosarcoma (MFS) is a common soft tissue sarcoma of the elderly that typically shows low tumor mutational burden, with mutations in TP53 and genes associated cell cycle checkpoints ( RB1 , CDKN2A ). Unfortunately, no alterations or markers specific to MFS have been identified and, as consequence, there are effective targeted therapies. The receptor tyrosine kinase AXL, which drives cellular proliferation, targetable by new antibody-based therapeutics. Expression AXL messenger RNA...

10.1097/pas.0000000000002191 article EN The American Journal of Surgical Pathology 2024-02-19
Coming Soon ...